Physician profile
Alan R Gilbert
NPI 1215961677
$1,026.13
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $294.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $222.07 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $143.64 | 2019-2020 | |
| Lilly USA, LLC | $116.80 | 2019 | |
| Amgen INC. | $96.54 | 2019-2020 | |
| Abbvie INC. | $82.65 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $72.06 | 2019-2020 | |
| Genzyme Corporation | $65.53 | 2019-2020 | |
| Pfizer INC. | $56.31 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $51.63 | 2019-2020 | |
| Genentech USA, INC. | $23.64 | 2019 | |
| Organogenesis INC. | $19.75 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.17 | 2019 | |
| Dusa Pharmaceuticals, INC. | $15.97 | 2019 | |
| Ucb, INC. | $15.23 | 2019 | |
| Leo Pharma INC. | $14.80 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aclaris Therapeutics, INC. | $13.34 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.